Treatment of migraine
Pro Research Analysisby 
Searched over 200M research papers
Acute Migraine Treatment Options: NSAIDs, Triptans, and New Drug Classes
For acute migraine attacks, first-line treatments include acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) for mild to moderate cases, while triptans are recommended for moderate to severe migraines. These medications are supported by strong evidence for their effectiveness and are widely used in clinical practice Mayans2018Ong2017Becker2015. Triptans, which act as 5-HT1B/1D receptor agonists, have been the standard of care but may not be suitable for patients with cardiovascular risks due to their vasoconstrictive properties De Vries2020Negro2019.
Other options for acute attacks include combination analgesics, antiemetics, and ergot alkaloids like dihydroergotamine, which are considered second- or third-line therapies, especially for patients who do not respond to first-line treatments Mayans2018Becker2015. The choice of medication should be individualized based on the severity of attacks, patient comorbidities, and previous response to treatments Ong2017Becker2015.
Preventive Migraine Treatments: CGRP-Targeted Therapies and Beyond
Preventive treatment is important for patients with frequent or disabling migraines. Recent advances have led to the development of drugs targeting the calcitonin gene-related peptide (CGRP) pathway. These include monoclonal antibodies such as eptinezumab, fremanezumab, galcanezumab, and erenumab, as well as small-molecule antagonists known as gepants (e.g., rimegepant, ubrogepant, and atogepant) De Vries2020Negro2019Zobdeh2021. These therapies have shown promise in reducing migraine frequency and are generally well tolerated, with ongoing studies assessing their long-term safety De Vries2020Negro2019Zobdeh2021.
Other preventive options include topiramate and botulinum toxin A, which have demonstrated efficacy in chronic migraine, as well as behavioral interventions like cognitive behavioral therapy, biofeedback, and relaxation techniques Cho2017Ashina2021.
Personalized and Integrated Migraine Management
Migraine treatment should be tailored to the individual, considering genetic factors, comorbidities, and potential drug-drug interactions. Personalized medicine aims to optimize therapy by accounting for differences in drug metabolism and response, which can be influenced by genetic variations in enzymes and receptors Pomes2019Ashina2021.
A multidisciplinary approach that combines pharmacological and non-pharmacological therapies, such as neuromodulation and behavioral interventions, can improve outcomes, especially in patients with chronic or refractory migraine Ashina2021Cho2017.
Emerging and Future Migraine Therapies
Despite recent progress, many patients still do not achieve satisfactory relief with current treatments. Research is ongoing to identify new therapeutic targets involved in pain processing, vasodilation, and central nervous system pathways. Future therapies may focus on these novel targets to provide more effective and tolerable options for migraine sufferers Chiang2024Zobdeh2021.
Conclusion
Migraine treatment has evolved significantly, with a range of acute and preventive options now available. NSAIDs, triptans, and CGRP-targeted therapies form the core of current pharmacological management, while personalized and integrated approaches help address individual patient needs. Ongoing research into new drug targets and therapies holds promise for further improving migraine care and outcomes De Vries2020Mayans2018Ong2017+7 MORE.
Sources and full results
Most relevant research papers on this topic